Table 1.

Indications of 213 MIALR cases.

Disease	n (%)
Hepatocellular carcinoma	104 (48.4%)
Metastatic tumor	72 (33.8%)
Intrahepatic cholangiocarcinoma	16 (7.5%)
Benign liver disease	11 (5.2%)
Malignant lymphoma	3 (1.4%)
Others	7 (3.3%)

n = 213.